Internal Medicine · New York, NY
NPI
1043367204
Since 2007
Specialty
Internal Medicine
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
80 5th Ave, Room 1601
New York, NY, 10011
Phone (212) 645-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,605 services
Medicare patients, 2024
172
Average age 77
Drug cost, 2024
$700K
1,956 prescriptions
Company payments, 2025
$560
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Liguori was code 99442 (telephone services), 326 times for 118 patients. In total Michael A Liguori billed 1,605 services in 32 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 326 | 118 | $73.52 | $24K |
| 36415 Venipuncture Blood Collection | Office | 229 | 135 | $2.96 | $679 |
| 99214 Office E&M - Established | Office | 194 | 122 | $99.09 | $19K |
| 99441 Telephone Services | Office | 127 | 69 | $45.09 | $5,726 |
| 99497 Care Management/Coordination | Office | 124 | 123 | $62.32 | $7,728 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 101 | 101 | $144.01 | $15K |
| 99213 Office E&M - Established | Office | 80 | 63 | $72.92 | $5,833 |
| G0008 Administration of influenza virus vaccine | Office | 52 | 51 | $28.42 | $1,478 |
| 81002 Clinical Chemistry | Office | 51 | 47 | $3.41 | $174 |
| 93000 Electrocardiogram | Office | 50 | 42 | $12.33 | $617 |
| 90658 Vaccine Product | Office | 48 | 48 | $21.42 | $1,028 |
| 99443 Telephone Services | Office | 33 | 25 | $106.87 | $3,527 |
| 99215 Office E&M - Established | Office | 21 | 20 | $154.55 | $3,245 |
| 93306 Echocardiography (TTE/TEE) | Office | 19 | 18 | $109.75 | $2,085 |
| 69210 Other Organ Systems | Office | 19 | 19 | $32.82 | $624 |
By year: 2022 $113K for 1,635 services; 2023 $100K for 1,413 services; 2024 $104K for 1,605 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 229 | 135 | $2.96 | $679 |
| 81002 Clinical Chemistry | 51 | 47 | $3.41 | $174 |
| 82270 Immunoassay | 12 | 12 | $4.29 | $51.48 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Liguori prescribed most often to Medicare patients was Atorvastatin Calcium, with 185 prescriptions and refills. In total Michael A Liguori wrote 1,956 Medicare prescriptions that cost $700K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 185 | 481 | 53 | $1,959 |
| Zolpidem Tartrate Generic | 73 | 73 | 16 | $616 |
| Amlodipine Besylate Generic | 54 | 156 | 16 | $647 |
| Levothyroxine Sodium Generic | 53 | 156 | 17 | $635 |
| Losartan Potassium Generic | 51 | 145 | 16 | $595 |
| Metoprolol Succinate Generic | 49 | 131 | 18 | $804 |
| Diclofenac Sodium Generic | 47 | 47 | 22 | $540 |
| Rosuvastatin Calcium Generic | 46 | 122 | 17 | $1,191 |
| Tivicay Dolutegravir Sodium | 39 | 39 | Under 11 | $86K |
| Sertraline Hcl Generic | 38 | 98 | Under 11 | $503 |
| Descovy Emtricitabine/Tenofov Alafenam | 38 | 38 | Under 11 | $88K |
| Ezetimibe Generic | 37 | 91 | Under 11 | $809 |
| Omeprazole Generic | 36 | 72 | 14 | $433 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 36 | 38 | Under 11 | $150K |
| Famotidine Generic | 34 | 100 | 13 | $863 |
Brand drugs: - claims; generic drugs: 1,560 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Liguori $560 ($560 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $147.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 12 | $147 |
| Gilead Sciences, Inc. GILD | 7 | $136 |
| Lilly USA, LLC LLY | 3 | $68.53 |
| Merck Sharp & Dohme LLC MRK | 2 | $56.66 |
| Pfizer Inc. PFE | 2 | $49.74 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.31 |
| GlaxoSmithKline, LLC. GSK | 1 | $24.49 |
| Novo Nordisk Inc NVO | 1 | $23.73 |
| Esperion Therapeutics, Inc. ESPR | 1 | $22.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.